Found: 11
Select item for more details and to access through your institution.
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML.
- Published in:
- Clinical Epigenetics, 2017, v. 9, p. 1, doi. 10.1186/s13148-017-0411-x
- By:
- Publication type:
- Article
Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 690, doi. 10.1007/s10637-019-00816-1
- By:
- Publication type:
- Article
Treatment of relapsed/refractory severe aplastic anemia in children: Evidence‐based recommendations.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31075
- By:
- Publication type:
- Article
Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31070
- By:
- Publication type:
- Article
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 2, p. 1, doi. 10.1002/pbc.28787
- By:
- Publication type:
- Article
Results from an international phase 2 study of the anti-CD22 immunotoxin moxetumomab pasudotox in relapsed or refractory childhood B-lineage acute lymphoblastic leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 230, doi. 10.1002/pbc.24278
- By:
- Publication type:
- Article
Phase I dose-escalation trial of clofarabine followed by escalating doses of fractionated cyclophosphamide in children with relapsed or refractory acute leukemias.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 7, p. 1252, doi. 10.1002/pbc.24264
- By:
- Publication type:
- Article